Using causal-inference methods and a matched comparison group, this is one of the first studies to show what actually happens to body composition in a large, diverse, real-world population
GLP-1 patient trends: demographics and adherence patterns Usage across the population A nationally representative survey conducted by RAND found that 11.8% of Americans have used GLP-1 drugs for weight loss, and about 14% express interest, while 74% say they do not plan to take them
Gastrointestinal Side Effects Associated with Ozempic The most frequently reported adverse effects of Ozempic involve the gastrointestinal system, affecting a substantial proportion of patients, particularly during treatment initiation
Prescription weight loss medications Insurance coverage may be available for patients with a BMI over 30, or over 27 with a qualifying health condition
& Blicher, J
Clinical trials report up to 12.4% weight loss, and it stands out for its flexible dosing